Additional information
603137-43-5-free base
White Powder
1391054-49-1
ACI-015213
(1-[({3-[2-(dimethylamino)ethyl]indol-5-yl}methyl)sulfonyl]pyrrolidine N-oxide hydrochloride)
(1-[({3-[2-(dimethylamino)ethyl]indol-5-yl}methyl)sulfonyl]pyrrolidine N-oxide hydrochloride)
Hygroscopic
C17H26ClN3O3S
387.9
Ambient
2-8°C
Almotriptan N-Oxide Hydrochloride Salt
Neurological disorder
Pharmaceutical Impurity Standards





![N-METHYL REGADENOSON (25 mg) (1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N,N-dimethylpyrazole-4-carboxamide )](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)
 
                    